TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

Clinical trial NCT04294264 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04294264
Sponsor: Rutgers, The State University of New Jersey
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Carcinoma Recurrent Colon Carcinoma Refractory Colorectal Carcinoma Stage IV Colon Cancer AJCC v7 Stage IVA Colon Cancer AJCC v7 Stage IVB Colon Cancer AJCC v7

Start date: 2019-02-12
Primary completion: 2024-03-27
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.